LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 26.70 | 17.25 | 782 | 1466 | 0.5332 | 0.8131 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 26.70 | 17.25 | 6 | 1466 | 0.0041 | -0.1519 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 26.70 | 17.25 | 851 | 1466 | 0.5802 | 0.8372 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 28.67 | 17.25 | 793 | 1653 | 0.4797 | 0.7888 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 28.67 | 17.25 | 6 | 1653 | 0.0036 | -0.1482 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 28.67 | 17.25 | 894 | 1653 | 0.5408 | 0.8217 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.64 | 17.25 | 1 | 1887 | 0.0005 | -0.3433 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.64 | 17.25 | 828 | 1887 | 0.4387 | 0.7709 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.64 | 17.25 | 10 | 1887 | 0.0053 | -0.0774 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.64 | 17.25 | 941 | 1887 | 0.4986 | 0.8047 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.61 | 17.25 | 1 | 2136 | 0.0005 | -0.3361 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.61 | 17.25 | 870 | 2136 | 0.4072 | 0.7576 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.61 | 17.25 | 11 | 2136 | 0.0051 | -0.0627 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.61 | 17.25 | 965 | 2136 | 0.4517 | 0.7840 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.57 | 17.25 | 1 | 2523 | 0.0004 | -0.3270 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.57 | 17.25 | 884 | 2523 | 0.3504 | 0.7286 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.57 | 17.25 | 3 | 2523 | 0.0012 | -0.2159 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.57 | 17.25 | 998 | 2523 | 0.3955 | 0.7580 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.54 | 17.25 | 1 | 2679 | 0.0004 | -0.3238 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.54 | 17.25 | 923 | 2679 | 0.3444 | 0.7276 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.54 | 17.25 | 1 | 2679 | 0.0004 | -0.3238 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.54 | 17.25 | 1029 | 2679 | 0.3840 | 0.7536 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.51 | 17.25 | 2 | 2906 | 0.0007 | -0.2527 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.51 | 17.25 | 944 | 2906 | 0.3248 | 0.7179 | MN20160310_N02 | C15 |